Serina Therapeutics SER
NYSE SER
$2.87 +0.22 (+8.53%)
As of: Aug 21, 2026 · 3:59 PM EDT

Serina Therapeutics (SER) EBIT Margin (QoQ) (2018 - 2024)

Serina Therapeutics (SER) EBIT Margin (QoQ) (2018 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Serina Therapeutics 46.70 Mn 23.67 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 7.76 Mn
Sep 30, 2024 -3.04 Mn
Jun 30, 2024 3.88 Mn
Mar 31, 2024 -4.64 Mn
Dec 31, 2023 505,263.00
Sep 30, 2023 845,517.00
Jun 30, 2023 -1.03 Mn
Mar 31, 2023 1.91 Mn
Dec 31, 2022 -505,278.00
Sep 30, 2022 -396,389.00
Jun 30, 2022 2.78 Mn
Mar 31, 2022 -3.99 Mn
Dec 31, 2021 580,812.00
Sep 30, 2021 -101,554.00
Jun 30, 2021 -205,410.00
Mar 31, 2021 -243,257.00
Dec 31, 2020 200,113.00
Sep 30, 2020 178,831.00
Jun 30, 2020 -188,245.00
Mar 31, 2020 -288,506.00